Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ThromboGenics
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female aged 18 years or older
Type 1 or type 2 Diabetes Mellitus
Central-involved DME with central subfield thickness of ≥ 320µm on Spectralis® spectral domain optical coherence tomography (SD-OCT) or ≥ 305µm on non-Spectralis SD-OCT, in the study eye
Best-corrected visual acuity (BCVA) ≤ 62 and ≥ 23 ETDRS letter score in the study eye
Written informed consent obtained from the subject prior to screening procedures
You may not be if
Macular edema due to causes other than DME
Concurrent disease in the study eye, other than central-involved DME, that could compromise BCVA, require medical or surgical intervention during the study period or could confound interpretation of the results
Any condition that could confound the ability to detect a change in central subfield thickness in the study eye
Previous confounding treatments / procedures, or expected to require confounding treatments / procedures at any time during the study period
Presence of neovascularization at the disc (NVD) in the study eye
Uncontrolled glaucoma in the study eye
Any active ocular / intra-ocular infection or inflammation in either eye
